🔴 Ardelyx is trading 5% down amid tech-led market weakness

Ardelyx is trading at $3.10, down 5.05%, with tech-sector selling and a rotation away from riskier growth stocks offering the clearest context.

• No fresh company-specific catalyst clearly explains the October 16 decline.
• A securities-lawsuit deadline reminder describes allegations tied to Ardelyx’s August guidance changes, not a new event explaining the move.
• The Nasdaq was down 2.16%, the S&P 500 was down 1.21%, and biotech ETF XBI was down 2.06%.